GraphWear Technologies

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s…

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor